Piramal Pharma Limited (PPLPHARMA)
₹201.15
INR-1.34(-0.66%)
As of July 8, 2025 9:50:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹27014.26 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹31248.23 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
303.88
Forward P/E
Price to Earnings ratio based on forecasted earnings
43.35
PEG Ratio
Price/Earnings to Growth ratio
0.77
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.95
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
65.32%
Operating Margin
Operating income as a percentage of revenue
11.56%
Return on Equity
Net income as a percentage of shareholders' equity
1.14%
Revenue (TTM)
Total revenue over trailing 12 months
₹9151.18 Cr+7.9%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1652.57 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹0.67+51.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹521.02 Cr
Total Debt
Total short-term and long-term debt
₹4856.47 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
59.77%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹145.25 - ₹307.9
Beta
Measure of stock's volatility compared to the market
0.08
Shares Outstanding
Total number of shares issued by the company
₹132.04 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.07%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.07%
Payout Ratio
Percentage of earnings paid as dividends
16.18%
